Literature DB >> 25684450

A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors.

Weixuan Yu1, Carla Neckles1, Andrew Chang1, Gopal Reddy Bommineni1, Lauren Spagnuolo1, Zhuo Zhang1, Nina Liu1, Christina Lai2, James Truglio2, Peter J Tonge3.   

Abstract

The classical methods for quantifying drug-target residence time (tR) use loss or regain of enzyme activity in progress curve kinetic assays. However, such methods become imprecise at very long residence times, mitigating the use of alternative strategies. Using the NAD(P)H-dependent FabI enoyl-acyl carrier protein (enoyl-ACP) reductase as a model system, we developed a Penefsky column-based method for direct measurement of tR, where the off-rate of the drug was determined with radiolabeled [adenylate-(32)P]NAD(P(+)) cofactor. In total, 23 FabI inhibitors were analyzed, and a mathematical model was used to estimate limits to the tR values of each inhibitor based on percentage drug-target complex recovery following gel filtration. In general, this method showed good agreement with the classical steady-state kinetic methods for compounds with tR values of 10 to 100 min. In addition, we were able to identify seven long tR inhibitors (100-1500 min) and to accurately determine their tR values. The method was then used to measure tR as a function of temperature, an analysis not previously possible using the standard kinetic approach due to decreased NAD(P)H stability at elevated temperatures. In general, a 4-fold difference in tR was observed when the temperature was increased from 25 to 37 °C.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Enoyl ACP reductase; High-throughput screening; Methodology; Penefsky column; Residence time (t(R)); Steady-state kinetics

Mesh:

Substances:

Year:  2015        PMID: 25684450      PMCID: PMC4454744          DOI: 10.1016/j.ab.2014.12.022

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  43 in total

1.  A centrifuged-column procedure for the measurement of ligand binding by beef heart F1.

Authors:  H S Penefsky
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

3.  Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet.

Authors:  Yasmina Abdiche; Dan Malashock; Alanna Pinkerton; Jaume Pons
Journal:  Anal Biochem       Date:  2008-03-25       Impact factor: 3.365

4.  Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.

Authors:  Joost C M Uitdehaag; Cecile M Sünnen; Antoon M van Doornmalen; Nikki de Rouw; Arthur Oubrie; Rita Azevedo; Michael Ziebell; Elliott Nickbarg; Willem-Jan Karstens; Simone Ruygrok
Journal:  J Biomol Screen       Date:  2011-08-26

5.  Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis.

Authors:  S Parikh; D P Moynihan; G Xiao; P J Tonge
Journal:  Biochemistry       Date:  1999-10-12       Impact factor: 3.162

6.  Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei.

Authors:  Nina Liu; Jason E Cummings; Kathleen England; Richard A Slayden; Peter J Tonge
Journal:  J Antimicrob Chemother       Date:  2011-01-22       Impact factor: 5.790

7.  Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.

Authors:  Christopher W am Ende; Susan E Knudson; Nina Liu; James Childs; Todd J Sullivan; Melissa Boyne; Hua Xu; Yelizaveta Gegina; Dennis L Knudson; Francis Johnson; Charles A Peloquin; Richard A Slayden; Peter J Tonge
Journal:  Bioorg Med Chem Lett       Date:  2008-04-18       Impact factor: 2.823

8.  Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity.

Authors:  Hao Lu; Kathleen England; Christopher am Ende; James J Truglio; Sylvia Luckner; B Gopal Reddy; Nicole L Marlenee; Susan E Knudson; Dennis L Knudson; Richard A Bowen; Caroline Kisker; Richard A Slayden; Peter J Tonge
Journal:  ACS Chem Biol       Date:  2009-03-20       Impact factor: 5.100

9.  Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.

Authors:  Andrew Chang; Johannes Schiebel; Weixuan Yu; Gopal R Bommineni; Pan Pan; Michael V Baxter; Avinash Khanna; Christoph A Sotriffer; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2013-06-06       Impact factor: 3.162

10.  Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1.

Authors:  Kelly Anderson; Zhihong Lai; Octerloney B McDonald; J Darren Stuart; Eldridge N Nartey; Mary Ann Hardwicke; Ken Newlander; Dashyant Dhanak; Jerry Adams; Denis Patrick; Robert A Copeland; Peter J Tummino; Jingsong Yang
Journal:  Biochem J       Date:  2009-05-13       Impact factor: 3.857

View more
  5 in total

1.  Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors.

Authors:  Lauren A Spagnuolo; Sandra Eltschkner; Weixuan Yu; Fereidoon Daryaee; Shabnam Davoodi; Susan E Knudson; Eleanor K H Allen; Jonathan Merino; Annica Pschibul; Ben Moree; Neil Thivalapill; James J Truglio; Joshua Salafsky; Richard A Slayden; Caroline Kisker; Peter J Tonge
Journal:  J Am Chem Soc       Date:  2017-02-22       Impact factor: 15.419

2.  Rational Modulation of the Induced-Fit Conformational Change for Slow-Onset Inhibition in Mycobacterium tuberculosis InhA.

Authors:  Cheng-Tsung Lai; Huei-Jiun Li; Weixuan Yu; Sonam Shah; Gopal R Bommineni; Victoria Perrone; Miguel Garcia-Diaz; Peter J Tonge; Carlos Simmerling
Journal:  Biochemistry       Date:  2015-07-24       Impact factor: 3.162

3.  Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.

Authors:  Carla Neckles; Sandra Eltschkner; Jason E Cummings; Maria Hirschbeck; Fereidoon Daryaee; Gopal R Bommineni; Zhuo Zhang; Lauren Spagnuolo; Weixuan Yu; Shabnam Davoodi; Richard A Slayden; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2017-03-21       Impact factor: 3.162

4.  Quantifying the Interactions between Biomolecules: Guidelines for Assay Design and Data Analysis.

Authors:  Peter J Tonge
Journal:  ACS Infect Dis       Date:  2019-04-13       Impact factor: 5.084

5.  Impact of Target Turnover on the Translation of Drug-Target Residence Time to Time-Dependent Antibacterial Activity.

Authors:  Rajeswari Basu; Nan Wang; Sneha Basak; Fereidoon Daryaee; Mustufa Babar; Eleanor K Allen; Stephen G Walker; John D Haley; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2021-08-06       Impact factor: 5.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.